Position in NTRA
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$433,234
+$305,641 QoQ
Shares Held
1,596
+150.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#559
of 844 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NTRA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026LRI Investments, LLC holds $6,589,239 across 23 Diagnostics & Research names. NTRA ranks #3 (6.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IQV |
Iqvia Holdings Inc.
|
23,909 | $4,619,696 | |
| 2 | DHR |
Danaher Corp /De/
|
3,317 | $631,821 | |
| 3 | NTRA |
Natera, Inc.
This page
|
1,596 | $433,234 | |
| 4 | TMO |
Thermo Fisher Scientific Inc.
|
757 | $379,529 | |
| 5 | DGX |
Quest Diagnostics Inc
|
1,026 | $217,460 | |
| 6 | MEDP |
Medpace Holdings, Inc.
|
186 | $98,503 | |
| 7 | IDXX |
Idexx Laboratories Inc /De
|
146 | $76,859 | |
| 8 | WGS |
GeneDx Holdings Corp.
|
837 | $57,460 |
All Filings in NTRA
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $433,234 | 1,596 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $127,593 | 638 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $156,468 | 683 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $93,040 | 578 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $84,638 | 501 | Shares | Sole | 2025-07-25 | |
| 2025-03-31 | $12,444 | 88 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $28,810 | 182 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||